Systemic Corticosteroids Do Not Need to Be Discontinued Prior to Allergy Testing in Children
There is no need to discontinue oral or inhaled systemic corticosteroids before performing allergy skin testing in children. 1
Key Evidence
The most relevant guideline evidence comes from the 2009 Anaesthesia guidelines on suspected anaphylactic reactions, which explicitly states: "There is no need to discontinue oral or inhaled steroids" before skin testing 1. This applies to both skin prick tests and intradermal tests used in allergy evaluation.
This recommendation is further supported by research demonstrating that long-term oral corticosteroid therapy (prednisone 10-60 mg/day for ≥2 years) does not alter skin prick test reactivity 2. In this prospective study of 33 patients with steroid-dependent asthma, median wheal diameters remained unchanged after prolonged systemic corticosteroid exposure, confirming that these medications do not suppress IgE-mediated skin test responses.
What DOES Need to Be Discontinued
In contrast, antihistamines must be discontinued several days before allergy testing because they directly suppress the histamine-mediated wheal and flare response that forms the basis of skin testing 3, 1. The guidelines specify that "drugs with anti-histamine activity must be discontinued a few days before testing" 1.
Clinical Algorithm for Pre-Testing Medication Management
For children requiring allergy testing:
- Systemic corticosteroids (oral or inhaled): Continue without interruption
- Antihistamines: Discontinue 3-7 days prior to testing (exact duration depends on the specific antihistamine's half-life)
- Topical corticosteroids: No discontinuation needed for skin testing at distant sites
Important Caveats
While systemic steroids don't interfere with immediate hypersensitivity testing, there is one specific exception: For delayed hypersensitivity testing (patch testing or delayed intradermal testing), systemic steroids >10 mg prednisone equivalent should be discontinued 4 weeks before testing 4. This applies specifically to evaluation of delayed drug reactions like DRESS syndrome, not routine environmental allergy testing.
The 2022 Drug Allergy Practice Parameter specifies that for patch testing and delayed intradermal testing, patients should wait "4 weeks after discontinuation of systemic steroids (>10 mg prednisone equivalent) or other immunosuppressants" 4. However, this is irrelevant for standard pediatric allergy testing for environmental allergens, which relies on immediate IgE-mediated responses.
Practical Implications
This evidence allows clinicians to proceed with allergy testing in children with asthma or other conditions requiring chronic corticosteroid therapy without treatment interruption. This is particularly important for children with poorly controlled asthma, where discontinuing inhaled or oral corticosteroids could precipitate dangerous exacerbations. The child can remain on their maintenance steroid regimen while undergoing skin prick testing or specific IgE blood testing to identify allergic triggers.